Apr 10, 2019 - Alkermes (ALKS) reports positive top-line data from phase IIIb study evaluating Aristada and Invega Sustenna in patients with acute exacerbations of schizophrenia.
Apr 09, 2019 - Good bargains are hard to find in today's market. Here are a few overlooked stocks for you to capitalize on.
Apr 05, 2019 - Novartis (NVS) announces plans to acquire IFM Tre, a subsidiary of IFM Therapeutics focused on anti-inflammatory drugs. Pfizer (PFE) & Teva's (TEVA) drugs get regulatory approvals in EU.
Apr 03, 2019 - Allergan's (AGN) MAPLE study evaluating a 12-week dose of abicipar pegol demonstrates decreased intraocular inflammation in nAMD patients.
Apr 03, 2019 - These under-the-radar stocks could be poised to make big moves in the coming months.
Apr 02, 2019 - Allergan (AGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Apr 01, 2019 - Spero???s (SPRO) SPR994 receives Fast Track designation by the FDA for the treatment of complicated urinary tract infections (cUTI) and acute pyelonephritis.
Mar 29, 2019 -
French director Agnès Varda, whose landmark films include “Cléo From 5 to 7” (1962) and “Vagabond” (1985), was saluted by her peers on Friday following her death at age 90.
She was a founding spirit of the French New Wave and a visionary creator, and filmmakers, film organizations and other creatives...
Mar 26, 2019 - Companies In The News Are:
BA, AGN, NKE, VIAB, T
Mar 21, 2019 - Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus